期刊文献+

粪肠球菌毒力因子gelE研究进展 被引量:3

The Research Progress of Enterococcus faecalis Virulence Factor gelE
下载PDF
导出
摘要 粪肠球菌与多种感染相关,明胶酶是其主要毒力因子之一,它影响粪肠球菌毒力,与粪肠球菌生物被膜形成有关。现对gelE在生物被膜形成中的作用进行综述。 Enterococcus faecalis associated with a variety of infections, gelatinase is one of the major virulence factor, it affects Enterococcus faecalis virulence, and Enterococcus faecalis biofilm formation. Now the author reviewed the gelErole in biofilm formation.
出处 《农学学报》 2015年第2期79-82,共4页 Journal of Agriculture
基金 内蒙古民族大学研究生科研项目"粪肠球菌TLME3株EfaA蛋白致病作用和免疫原性研究"(S10136201309)
关键词 粪肠球菌 明胶酶 生物被膜 Enterococcus faecalis Gelatinase Biofilm
  • 相关文献

参考文献16

  • 1Olesen H V, Moiler J K. Enterococcal infections.Clinical findings and treatment considering antibiotic resistance in Denmark[J]. Ugesker Laeger,2002,164( 18):2386-2390.
  • 2Sanchez-anchez-siols, Perez-Giraldo C, Martin P, et al. Pathogenicity of Enterococcus spp.Characteristics of 169 hospital isolates[J].Enferm Infecc Microbiol Clin,2000,18(4): 165-169.
  • 3Su Ya, Selavik M C, Makinen K K, et al.Nucleotide sequence of the Gelatinase gene (gelE) from Enterococcus faecalis subsp. Liquefaciens[J].Infect Immun, 1991,59(1 ):415 -420.
  • 4Coburm P S, Gilmore M S. The Enterococcus faecalis cytolysin:a novel toxin active against eukaryotic and prokaryotic cells[J].Cell Microbiol,2003,5(10):661-669.
  • 5李湘燕,郑波,李耘,等.粪肠球菌生物膜形成与esp、gelE基因的相关性分析[C].第六届全国抗菌药物临床药理学术会议论文集,2006.
  • 6Nakayama J, Tanaka E, Karuyama R, et al. Siamycin attenuates fsr Quorum Sensing mediated by a Gelatinase biosynthesis-activating pheromone in Enterococcus faecalis[J].J Bacteriol,2007,189(4): 1358- 1359.
  • 7马贵军,韩素娟,剡根强,周霞,王静梅.肠球菌毒力因子研究进展[J].动物医学进展,2007,28(6):66-69. 被引量:6
  • 8马立艳,许淑珍,马纪平.肠球菌致病机制的研究进展[J].中华医院感染学杂志,2005,15(3):356-360. 被引量:47
  • 9Creti R, Imperi M, Bertuccini L, et al. Surey for virulence determinants among Enterococcus faecalis isolated from different sources[J].J Med Microbiol,2004,53(1): 13-20.
  • 10Waters C M, Antiporta M H, Murray B E, et al. Role of the Enterococcus faecalis GelE protease in determination of cellular chain length,supernatant pheromone leves and degradation if fibrin and misfolded surface proteins[J].J Bacteriol,2003,185(12):3613- 3623.

二级参考文献68

  • 1王艳红,张扣兴.肠球菌感染的研究进展[J].国外医学(呼吸系统分册),2005,25(1):38-40. 被引量:18
  • 2马立艳,许淑珍,马纪平.肠球菌致病机制的研究进展[J].中华医院感染学杂志,2005,15(3):356-360. 被引量:47
  • 3吴利先,黄文祥.屎肠球菌耐万古霉素的分子生物学机制及毒力因子[J].国际流行病学传染病学杂志,2006,33(2):132-135. 被引量:11
  • 4De Clercq E.Antiviral drugs:current state of art [J].J Clin Virol,2001,22(1):73-89.
  • 5Harris M,Montaner JSG.Clinical uses of non2nucleoside reverse transcriptase inhibitors[J].Rev Med Virol,2000,10:217-229.
  • 6Smith PF,DiCenzo R,Morse GD.Clinical pharmacokinetics of nonnucleoside reverse transcriptase inhibitors[J].Clin Pharmacokinet,2001,40(12):893-905.
  • 7GadiB,Dom inique A,M arka W,ET al.The thicarboxanilide nonnucleoside inhibitor UC781 resto resantiviral activity of (AZT)againt AZT-resistant human immunodeficiency virus type 1[J].Antimicrob Agent Chemother,1999,43(2):259.
  • 8Barreiro P,Soriano V,Blanco F,et al.Risks and benefits of replacing protease inhibitors by nevirapine in HIV2infected subjects under longterm successful triple combination therapy[J].AIDS,2000,14(7):807-812.
  • 9Rober Craigie.HIV integrase,a brief overview from chemistry to therapeutics[J].J Biol Chem,2001,276(26):23213-23216.
  • 10Hazucla DJ,Felock P,Witmer M,et al.Inhibitor of strand transfer that prevent integration and inhibit HIV21 replication in cells [J].Science,2000,287(5453):646-650.

共引文献60

同被引文献35

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部